Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 28, 2026
Why Is Lam Research (LRCX) Stock Down -8.20% Today?

Why Is Lam Research (LRCX) Stock Down -8.20% Today?

Key Takeaways

  • Lam Research (LRCX) shares plunged 8.20% on Tuesday, extending a brutal July selloff that has erased roughly one-third of the stock's value in a single month.
  • The primary catalyst is a sector-wide rout in semiconductor equipment stocks triggered by reports that a Chinese state-backed company has begun mass-producing homegrown immersion DUV lithography machines.
  • Secondary drivers include mounting concerns about the sustainability of AI-driven capital expenditure, profit-taking after a parabolic first-half rally, and anxiety ahead of Lam Research's upcoming earnings report.
  • Broader market context shows the Philadelphia Semiconductor Index falling sharply, with South Korea's KOSPI triggering a circuit breaker as memory names like SK Hynix and Samsung plunged double digits.
  • Traders are closely watching Lam Research's fiscal fourth-quarter earnings, scheduled for July 29, which could either stabilize the selloff or deepen it depending on guidance.

Opening Summary

LRCX, Lam Research Corporation — a global leader in semiconductor wafer fabrication equipment specializing in etch and deposition technologies — saw its shares tumble 8.20% in Tuesday's trading session. The stock fell to approximately $267.71, down sharply from Monday's closing price of $291.61, as a powerful wave of selling swept through the entire semiconductor equipment complex. The decline marks the latest leg in a punishing July for the stock, which has now shed more than 30% from its 52-week high of $438.50 reached in late June.

China's DUV Lithography Breakthrough Rocks the Sector

The dominant force behind Tuesday's selloff was a report from The Information revealing that a Shanghai-based, state-backed enterprise has commenced small-scale production of domestically developed immersion deep ultraviolet (DUV) lithography machines. The company reportedly plans to manufacture approximately five DUV systems in 2026 and roughly 20 in 2027, with initial deliveries earmarked for major Chinese chipmakers including SMIC, Hua Hong Semiconductor, and CXMT.

While Lam Research does not manufacture lithography equipment — its core expertise lies in etching and thin-film deposition — the news sent a shockwave across the entire semiconductor capital equipment industry. Investors swiftly repriced the risk that China's growing self-sufficiency in critical chipmaking tools could erode the long-term addressable market for Western equipment suppliers. The logic driving the selloff was clear: if China can conquer lithography, the most technologically challenging link in the semiconductor supply chain, then other equipment categories — including etch and deposition — may eventually face domestic competition as well.

ASML, the Dutch lithography giant, bore the brunt of the selling with shares dropping over 5%, while AMAT (Applied Materials) and KLAC (KLA Corporation) also fell sharply. Several Wall Street analysts, including JPMorgan, described the selloff as "disproportionate" given the limited scale of Chinese production and the performance gap that still exists versus ASML's proven systems, but the damage to sentiment was already done.

AI Capex Jitters and Profit-Taking Compound the Pressure

Beyond the China headline, broader anxiety about the pace and durability of AI infrastructure spending continued to weigh on semiconductor equipment names. Lam Research had surged approximately 154% in the first half of 2026, driven by insatiable demand for AI-capable chips and a corresponding boom in wafer fabrication equipment orders. That extraordinary rally left the stock trading at elevated valuation multiples — a forward P/E ratio of roughly 39 times earnings — making it acutely vulnerable to any shift in narrative.

Recent questions about whether hyperscale cloud providers can sustain their torrid spending pace have provided ample reason for profit-taking. Reports that Meta Platforms may lease excess AI computing capacity raised concerns about overbuilding, while a Citi analyst warning about cooling wafer fab equipment orders added fuel to the fire. The simultaneous listing of Chinese memory maker CXMT in Shanghai — which surged 466% on its debut — further highlighted the competitive threat that domestic Chinese chipmakers pose to the global semiconductor order.

Market Context and Trading Activity

Trading volume in LRCX was significantly elevated relative to its daily average, reflecting the intensity of the selling pressure. The Philadelphia Semiconductor Index fell more than 2% on Monday and continued to weaken on Tuesday, while the broader Nasdaq composite also traded in negative territory, though its declines were far milder than those suffered by chip equipment stocks.

The selloff extended well beyond U.S. markets. South Korea's KOSPI index dropped 8%, triggering a circuit breaker, as memory chip giants SK Hynix and Samsung Electronics plunged more than 12% and 10%, respectively. This global rout underscores how deeply interconnected the semiconductor supply chain has become and how quickly sentiment can cascade across geographies and sub-sectors.

From a technical perspective, LRCX has now sliced through its 50-day and 200-day moving averages, both of which had provided support earlier in the year. The stock is trading at levels not seen since early 2026, effectively erasing months of gains in a matter of weeks.

What Comes Next for LRCX

The immediate focus for investors is Lam Research's fiscal fourth-quarter earnings report, scheduled for July 29. Analysts expect earnings per share of approximately $1.69 on revenue of $6.67 billion, representing year-over-year growth of 27% and 29%, respectively. The company's guidance and management commentary on order visibility will be scrutinized for any sign that the AI-driven equipment cycle is decelerating.

Longer-term, the China DUV story will continue to evolve. While most analysts agree that the immediate competitive threat is limited — five to twenty machines per year is a fraction of global demand — the psychological impact of China crossing the lithography threshold cannot be ignored. For Lam Research specifically, the approximately 34% to 35% of revenue that comes from China remains a double-edged sword: a crucial growth market but also a persistent source of geopolitical and export-control risk.

Investors will also monitor institutional positioning and insider activity. Several directors and executives have sold significant amounts of stock in recent months under pre-arranged trading plans, and while these sales are not necessarily indicative of bearish sentiment, they add to the cautious tone surrounding the name. The broader question of whether semiconductor equipment stocks have entered a cyclical peak or are merely experiencing a healthy correction within a secular growth story will likely dominate the narrative for the remainder of the summer.

Trending AI Robots

In volatile market environments like the one currently unfolding in semiconductor stocks, traders often turn to systematic strategies to navigate the turbulence. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under prevailing market conditions. With hundreds of bots covering thousands of tickers — including semiconductor names — the platform highlights only those strategies that are currently outperforming, spanning diverse approaches such as momentum, swing trading, and trend-following. Each bot varies by strategy, timeframe, and performance metrics, allowing users to identify approaches aligned with their trading style. Explore the Trending AI Robots to discover which algorithms are navigating today's markets most effectively.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LRCX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


LRCX's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for LRCX moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on LRCX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LRCX just turned positive on August 05, 2026. Looking at past instances where LRCX's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LRCX advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

LRCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

LRCX moved below its 50-day moving average on July 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LRCX crossed bearishly below the 50-day moving average on July 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LRCX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LRCX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LRCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LRCX's P/B Ratio (32.680) is very high in comparison to the industry average of (9.013). P/E Ratio (56.616) is within average values for comparable stocks, (176.968). Projected Growth (PEG Ratio) (1.517) is also within normal values, averaging (1.654). Dividend Yield (0.003) settles around the average of (0.006) among similar stocks. P/S Ratio (17.699) is also within normal values, averaging (38.579).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 67.85B. The market cap for tickers in the group ranges from 555.66K to 689.17B. ASML holds the highest valuation in this group at 689.17B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 7%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 46%. AEHR experienced the highest price growth at 31%, while SMTK experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 1%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 32
Price Growth Rating: 44
SMR Rating: 74
Profit Risk Rating: 60
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
LRCX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of semiconductor processing equipment

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
4650 Cushing Parkway
Phone
+1 510 572-0200
Employees
19000
Web
https://www.lamresearch.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.